Accendra Health (ACH) Stock Price, News & Analysis

Company Overview

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Key Stats

• Today's Range: $3.12 to $3.42
• 50-Day Range: $2.55 to $3.93
• 52-Week Range: $1.84 to $9.55
• Volume: 1.04 million shs
• Average Volume: 683,188 shs
• Market Capitalization: $251.20 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.17
• Consensus Rating: Hold

Accendra Health Stock Analysis - MarketRank™

Accendra Health scored higher than 56% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Hold

Consensus Rating

Accendra Health has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 2 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

Accendra Health has a consensus price target of $5.17, representing about 57.5% upside from its current price of $3.28.

Amount of Analyst Coverage

Accendra Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.1 / 5
• Proj. Earnings Growth: 54.84%

Earnings Growth

Earnings for Accendra Health are expected to grow by 54.84% in the coming year, from $0.31 to $0.48 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Accendra Health is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Accendra Health has a PEG Ratio of 5.13. PEG Ratios above 1 indicate that a company could be overvalued.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.11% of the float of Accendra Health has been sold short.

Short Interest Ratio / Days to Cover

Accendra Health has a short interest ratio ("days to cover") of 8.16.

Change versus previous month

Short interest in Accendra Health has recently increased by 3.76%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Accendra Health does not currently pay a dividend.

Dividend Growth

Accendra Health does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Accendra Health will have a dividend payout ratio of 20.83% next year. This indicates that Accendra Health will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Accendra Health this week, compared to 2 articles on an average week.

Search Interest

Only 3 people have searched for ACH on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Accendra Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.29% of the stock of Accendra Health is held by insiders.

Percentage Held by Institutions

Accendra Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/11/2026
• Today: 6/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: WHOLESALE - MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
• Sub-Industry: N/A
• Current Symbol: NYSE:ACH
• CIK: 75252
• Web: www.accendrahealth.com
• Phone: (804) 277-4304
• Fax: 804-723-7100
• Employees: 6,500
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Accendra Health: $5.17
• High Price Target: $6.00
• Low Price Target: $4.50
• Potential Upside/Downside: +57.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.20
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($14.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 10.58
• P/E Growth: 5.13
• Net Income: -$1.10 billion
• Net Margins: -39.84%
• Pretax Margin: -4.15%
• Return on Equity: -13.18%
• Return on Assets: 1.65%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.49
• Quick Ratio: 0.43

Sales & Book Value

• Annual Sales: $2.72 billion
• Price / Sales: 0.09
• Cash Flow: $3.77 per share
• Price / Cash Flow: 0.87
• Book Value: ($5.96) per share
• Price / Book: -0.55

Miscellaneous

• Outstanding Shares: 76,584,000
• Free Float: 74,830,000
• Market Cap: $251.20 million
• Optionable: N/A
• Beta: 1.62